Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

Abroad (travel likely)Recruiting

Conditions

Takayasu Arteritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Marmara University Pendik Training and Research Hospital, Istanbul, Turkey (Türkiye)
Contact: Study coordinator (Fatma Alibaz-Oner, MD) · falibaz@gmail.com

Study leads

Fatma Alibaz-Oner, MD
Principal Investigator
Marmara University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Takayasu Arteritis

Abroad (travel likely)RecruitingPHASE4

Shanghai, China

A Pilot Study in Severe Patients With Takayasu Arteritis.

Takayasu Arteritis · Tocilizumab · Adalimumab

Abroad (travel likely)RecruitingPHASE4

Shanghai, China

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE4

São Paulo, Brazil · São Paulo, Brazil

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

Myocarditis · ANCA Associated Vasculitis · Pericarditis

Abroad (travel likely)Recruiting

Paris, France